Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Exposure During Pregnancy Clinical Trial

Official title:
Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Status Completed

Clinical Trial Summary

The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development of the fetus/infant at birth and for the first 2 years will also be followed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Exposure During Pregnancy

Clinical Trial Details

NCT number	NCT02556775
Study type	Observational [Patient Registry]
Source	Takeda
Contact
Status	Completed
Phase
Start date	December 4, 2015
Completion date	December 17, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01911767` - Biogen Multiple Sclerosis Pregnancy Exposure Registry
Active, not recruiting	`NCT04108728` - Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )	N/A
Completed	`NCT04493892` - Hair Care Product Use Among Women Of Color	N/A
Completed	`NCT05803200` - A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy
Not yet recruiting	`NCT04492449` - Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection